A United Kingdom supplier, with 6 awarded contracts, totalling £566.9m, most recently 6 months ago.
This public procurement contract involves the ongoing supply of a medicinal product containing the active substance nusinersen (ATC M09AX07). The specific product is LL-nusinersen, in the form of a 2MG injection solution packaged as 1X5ML. The total quantity required is 200 units. This contract is i
This public procurement contract involves the supply of medicinal products, nutritional supplements, and selected medical devices intended for use in the clinics and departments of Bulovka University Hospital. Suppliers are invited to provide these essential goods to support healthcare services.
This public procurement contract involves the supply of medicinal products, nutritional supplements, and selected medical devices intended for use in the clinics and departments of Bulovka University Hospital. Suppliers are invited to participate in a dynamic purchasing system (DPS) that facilitates
This contract involves the ongoing supply of the medication Etanercept (L04AB01) as detailed in Appendix 1 of the Purchase Agreement – Price Offer. Suppliers are expected to deliver these pharmaceutical products in accordance with the specified procurement conditions.
This public procurement contract involves the ongoing supply of pharmaceuticals containing the active ingredients L04AX07 Dimethyl Fumarate and L04AG03 Natalizumab for a duration of 3 years. The contract is valued at approximately 71,726,201.4 CZK and is intended for the health sector. Suppliers int
This procurement contract involves establishing a framework agreement for the supply of medicinal products as required by the contracting authority. The focus is on medicinal products containing the active ingredient Efgartigimod Alfa. The total value of the contract is approximately 66 million Czec
